Loading...

APC/Cyanine7 anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_APCCyanine7_CD45_Antibody_013019_updated.png
C57BL/6 splenocytes were stained with CD45 (clone 30-F11) APC/Cyanine7 (filled histogram) or Rat IgG2b, κ APC/Cyanine7 isotype control (open histogram).
  • 30-F11_APCCyanine7_CD45_Antibody_013019_updated.png
    C57BL/6 splenocytes were stained with CD45 (clone 30-F11) APC/Cyanine7 (filled histogram) or Rat IgG2b, κ APC/Cyanine7 isotype control (open histogram).
Compare all formats See APC/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
103115 25 µg $98
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103116 100 µg $196
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  2. Naito H, et al. 2020. Nature Protocols. 15(3):1066-1081. PubMed
  3. Xing J, et al. 2021. Cell Reports. 35(12):109205. PubMed
  4. Heindl S, et al. 2021. J Exp Med. 218:. PubMed
  5. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  6. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  7. Ren Y, et al. 2021. Am J Transplant. 21:552. PubMed
  8. Hilfenhaus G, et al. 2021. Cancer Res. 81:619. PubMed
  9. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  10. Cohen K, et al. 2021. Cell Rep. 37:110026. PubMed
  11. Schnell A, et al. 2021. Cell. 184:6281. PubMed
  12. He D, et al. 2022. Immunity. 55:159. PubMed
  13. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  14. Goncharov NV, et al. 2022. J Evol Biochem Physiol. 58:230. PubMed
  15. Li DD, et al. 2022. J Cell Mol Med. 26:2438. PubMed
  16. Denorme F, et al. 2022. J Clin Invest. 132: . PubMed
  17. Tang Q, et al. 2022. Mol Ther. 30:2709. PubMed
  18. Chae CS, et al. 2022. Cancer Discov. 12:1904. PubMed
  19. Miyao T, et al. 2022. Elife. 11: . PubMed
  20. Serra M, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:609. PubMed
  21. Poh AR, et al. 2022. Sci Adv. 8:eabl7882. PubMed
  22. Campisi L, et al. 2022. Nature. 606:945. PubMed
  23. Kenigsbuch M, et al. 2022. Nat Neurosci. 25:876. PubMed
  24. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  25. Li F, et al. 2022. Gut Microbes. 14:2096989. PubMed
  26. Rodrigues PB, et al. 2022. Cells. 11: . PubMed
  27. Zhu J, et al. 2022. Research (Wash D C). 2022:9816272. PubMed
  28. Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed
  29. Zhu X, et al. 2023. Adv Mater. 35:e2207198. PubMed
  30. Li S, et al. 2022. Nat Commun. 13:7371. PubMed
  31. Morrow RJ, et al. 2022. Cells. 11: . PubMed
  32. Liu P, et al. 2023. Clin Immunol. 246:109212. PubMed
  33. Alula KM, et al. 2023. Sci Rep. 13:18. PubMed
  34. Peng Q, et al. 2023. EMBO Rep. 24:e56034. PubMed
  35. Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed
  36. Zhou J, et al. 2023. Nutrients. 15: . PubMed
  37. Slusarczyk P, et al. 2023. Elife. 12: . PubMed
  38. Cao Y, et al. 2023. J Inflamm Res. 16:343. PubMed
  39. Tsioti I, et al. 2023. J Neuroinflammation. 20:25. PubMed
  40. Li XF, et al. 2023. J Exp Med. 220: . PubMed
  41. Chun J, et al. 2023. Cancers (Basel). 15: . PubMed
  42. Drummer C, et al. 2023. Front Immunol. 14:1113883. PubMed
  43. Ishikawa T, et al. 2023. Bio Protoc. 13:e4588. PubMed
  44. Ryan CB, et al. 2022. Neurobiol Dis. 163:105608. PubMed
  45. Marsh SE, et al. 2022. Nat Neurosci. 25:306. PubMed
  46. Gomez-Salinero JM, et al. 2022. Cell Stem Cell. 29:593. PubMed
  47. Hailemichael Y, et al. 2022. Cancer Cell. 40:509. PubMed
  48. Korsunsky I, et al. 2022. Med. 3:481. PubMed
  49. Cheng C, et al. 2022. Cell Mol Gastroenterol Hepatol. 15:261. PubMed
  50. Pattwell SS, et al. 2022. Sci Adv. 8:eabo6789. PubMed
  51. Schroeter CB, et al. 2022. J Neuroinflammation. 19:270. PubMed
  52. Ho HM, et al. 2022. Pharmaceutics. 14:. PubMed
  53. Cai Z, et al. 2023. Adv Sci (Weinh). 10:e2207155. PubMed
  54. Banerjee K, et al. 2023. Eur J Immunol. 53:e2250161. PubMed
  55. Wu Z, et al. 2023. EMBO Rep. 24:e56524. PubMed
  56. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  57. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  58. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  59. Tang C, et al. 2023. Nat Commun. 14:1493. PubMed
  60. Saha S, et al. 2023. Sci Rep. 13:4609. PubMed
  61. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  62. Freitag PC, et al. 2023. Mol Ther Methods Clin Dev. 29:120. PubMed
  63. Thai LM, et al. 2023. iScience. 26:106477. PubMed
  64. He Q, et al. 2023. Parasit Vectors. 16:139. PubMed
  65. Sasaki L, et al. 2022. Nat Aging. 2:105. PubMed
  66. Haensel D, et al. 2023. Nat Commun. 14:2685. PubMed
  67. Lee K, et al. 2023. JCI Insight. 8:. PubMed
  68. Wang C, et al. 2023. Int J Oral Sci. 15:19. PubMed
  69. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
  70. Scieszka DP, et al. 2023. Respir Res. 24:138. PubMed
  71. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  72. Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed
  73. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  74. Contijoch EJ et al. 2019. eLife. 8 pii: e40553. PubMed
  75. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  76. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  77. Stefkovich M, et al. 2021. Mol Metab. 54:101357. PubMed
  78. Wang Q, et al. 2020. Radiat Environ Biophys. 59:89. PubMed
  79. Kim MY, et al. 2021. JCI Insight. 6:. PubMed
  80. De Vries LCS, et al. 2021. J Crohns Colitis. 15:617. PubMed
  81. Bernasconi R, et al. 2021. EMBO Mol Med. :e14392. PubMed
  82. Miranda K, et al. 2022. iScience. 25:104994. PubMed
  83. Da Mesquita S, et al. 2021. Nature. 593:255. PubMed
  84. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  85. Ren D, et al. 2022. STAR Protoc. 3:101217. PubMed
  86. Urban SK, et al. 2020. Liver Int. 40:3103. PubMed
  87. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  88. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  89. Kokona D, et al. 2016. Exp Eye Res. S0014-4835(16)30499-7. PubMed
  90. Page N, et al. 2018. Immunity. 48:937. PubMed
  91. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  92. Ajina R, et al. 2019. Oncoimmunology. 8:e1577127. PubMed
  93. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  94. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  95. Lyons J, et al. 2018. PLoS Biol. 16:e2002417. PubMed
  96. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  97. Wu SY, et al. 2022. Mol Cancer. 21:84. PubMed
  98. Effern M, et al. 2022. STAR Protoc. 3:101038. PubMed
  99. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  100. Tripathi H, et al. 2020. J Mol Cell Cardiol. 149:95. PubMed
  101. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  102. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  103. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  104. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  105. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 5:64. PubMed
  106. Baram T, et al. 2021. Cells. 10:. PubMed
  107. Pan Y, et al. 2021. Front Cell Neurosci. 15:664312. PubMed
  108. Kashyap AS, et al. 2019. Cell Rep. 28:3367. PubMed
  109. Pluchino N, et al. 2020. J Cell Mol Med. 24:2464. PubMed
  110. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  111. Radovanovic I, et al. 2014. J Immunol. 193:1290. PubMed
  112. Evans H, et al. 2015. J Immunol. 195: 2973 - 2984. PubMed
  113. Cardona S, et al. 2015. ASN Neuro. 7: 1759091415608204. PubMed
  114. Zhu S, et al. 2022. Front Pharmacol. 13:996635. PubMed
  115. Palacios LM, et al. 2022. Biology (Basel). 11:. PubMed
  116. Ebneter A, et al. 2017. Transl Vis Sci Technol. 10.1167/tvst.6.2.10. PubMed
  117. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  118. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  119. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  120. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  121. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  122. Adrover JM, et al. 2022. JCI Insight. 7:. PubMed
  123. Steubing RD, et al. 2022. Brain Behav Immun Health. 24:100493. PubMed
  124. Lu H, et al. 2021. Autophagy. 17:2511. PubMed
  125. Kawashima N, et al. 2022. Nat Commun. 13:1624. PubMed
  126. Biswas S, et al. 2021. Nature. 591:464. PubMed
  127. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  128. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  129. Han Y, et al. 2020. Nat Commun. 11:1776. PubMed
  130. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  131. Haertel E, et al. 2018. Eur J Immunol. 48:1001. PubMed
  132. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  133. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  134. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  135. Zhou X, et al. 2022. Front Pharmacol. 13:887263. PubMed
  136. Zhu B, et al. 2021. Immunity. 54(6):1200-1218.e9. PubMed
  137. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  138. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  139. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  140. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  141. Wiley CD, et al. 2019. JCI Insight. 4:e130056. PubMed
  142. Krasteva G, et al. 2011. Proc Natl Acad Sci U S A. 108:9478. PubMed
  143. Khandelwal P, et al. 2013. PLoS One. 8:64193. PubMed
  144. Shibata K, et al. 2014. J Immunol. 192:2210. PubMed
  145. Mantia-Smaldone G, et al. 2014. Gynecol Oncol. 133:584. PubMed
  146. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  147. AR P, et al. 2016. Circ Res. 118: 400-409. PubMed
  148. Ganeshan K et al. 2019. Cell. 177(2):399-413 . PubMed
  149. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  150. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  151. Armaka M, et al. 2022. Genome Med. 14:78. PubMed
  152. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  153. Jung BG, et al. 2022. PLoS Pathog. 18:e1010454. PubMed
  154. Bagayoko S, et al. 2021. PLoS Pathog. 17:e1009927. PubMed
  155. Dieterich LC, et al. 2019. International Journal of Cancer. 145(10):2804-2815. PubMed
  156. Marangoni F, et al. 2021. Cell. . PubMed
  157. Wang LT, et al. 2021. STAR Protocols. 2(1):100337. PubMed
  158. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  159. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  160. Huang B, et al. 2020. Cell. 179(5):1160-1176.e24.. PubMed
  161. Ning F, et al. 2019. J Exp Med. 216:1396. PubMed
  162. Chew W, et al. 2016. Nat Methods. 13: 868-874. PubMed
  163. Cordeiro O, et al. 2016. PLoS One. 11: 0151848. PubMed
  164. Higashi AY, et al. 2019. J Am Soc Nephrol. 30:80. PubMed
  165. Lyons J, et al. 2018. Sci Signal. 11. PubMed
  166. Evans R, et al. 2019. Cell Rep. 27:1967. PubMed
  167. Hammond TR, et al. 2019. Immunity. 50:253. PubMed
  168. Schönfeld M, et al. 2021. Alcohol Clin Exp Res. 45:1980. PubMed
  169. Bhattacherjee A, et al. 2021. Mol Neurodegener. 16:19. PubMed
  170. Liu M, et al. 2020. Cell Rep. 32:107990. PubMed
  171. Jeljeli M, et al. 2020. Cell Rep. 33:108325. PubMed
  172. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  173. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  174. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  175. Weiner AI, et al. 2019. NPJ Regen Med. 4:17. PubMed
  176. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  177. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  178. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  179. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  180. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  181. Commerford CD et al. 2018. Cell reports. . PubMed
  182. Zeng J, et al. 2019. Cell Rep. 27:549. PubMed
  183. Yousef H, et al. 2018. Bio Protoc. 8:22. PubMed
  184. Willingham SB, et al. 2018. Cancer Immunol Res. 6:1136. PubMed
  185. Donlan AN, et al. 2020. Anaerobe. 66:102275. PubMed
  186. Uher O, et al. 2021. Cancers (Basel). 13:. PubMed
  187. Gao H, et al. 2021. Cells. 10:. PubMed
  188. Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed
  189. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  190. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  191. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  192. Zhang X, et al. 2020. Elife. 9:00. PubMed
  193. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  194. Chun E, et al. 2020. Immunity. 51(5):871-884.e6.. PubMed
  195. Bahar Halpern K, et al. 2020. Nat Commun. 11:1936. PubMed
  196. Soldevilla MM, et al. 2019. Mol Ther. 27:1878. PubMed
  197. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  198. JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
  199. Li Y, et al. 2019. Sci Rep. 9:6932. PubMed
  200. Mifflin L, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  201. Stewart JM, et al. 2020. ACS Biomater Sci Eng. 6:5941. PubMed
  202. Fu H, et al. 2020. Front Immunol. 11:595813. PubMed
  203. Oladiran O, et al. 2021. J Neuroinflammation. 77:18. PubMed
  204. Veremeyko T, et al. 2012. J Vis Exp. 65: 4097. PubMed
  205. Ayaub E,et al. 2017. Sci Rep.. 10.1038/s41598-017-13511-z. PubMed
  206. Peralta Ramos JM, et al. 2017. Front Immunol. 1.490277778. PubMed
  207. Halpern KB, et al. 2018. Nat Biotechnol. 36:962. PubMed
  208. Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed
  209. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  210. Ali M, et al. 2022. JCI Insight. 7:. PubMed
  211. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  212. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  213. Ghandhi SA, et al. 2022. Sci Rep. 12:14124. PubMed
  214. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  215. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  216. McFarland AP, et al. 2021. Immunity. 54(6):1320-1337.e4. PubMed
  217. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  218. Dieterich LC, et al. 2020. Angiogenesis. 1.24375. PubMed
  219. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  220. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  221. Martina M, et al. 2014. J Vis Exp. 87: 51192. PubMed
  222. Hu Y, et al. 2022. J Nanobiotechnology. 20:417. PubMed
  223. Haikala HM, et al. 2019. Nat Commun. 10:620. PubMed
  224. Neuhöfer P, et al. 2021. Nature. 597:715. PubMed
  225. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  226. Hum NR, et al. 2022. Front Oncol. 12:928474. PubMed
  227. Bergin SM, et al. 2021. Brain Behav Immun. 95:477. PubMed
  228. Selvaraj UM, et al. 2021. Brain Behav Immun. 95:502. PubMed
  229. Ying T, et al. 2021. Am J Physiol Endocrinol Metab. 320:E1148. PubMed
  230. Chen Y, et al. 2022. Front Immunol. 13:835690. PubMed
  231. Momin N, et al. 2022. Nat Commun. 13:109. PubMed
  232. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
  233. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  234. Dhanwani R, et al. 2020. Sci Adv. 6:eaba3688. PubMed
  235. Tripathi H, et al. 2020. Stem Cell Rev Rep. 0.953472222. PubMed
  236. Cardenas JJ, et al. 2020. Methods Enzymol. 415:631. PubMed
  237. Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed
  238. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
  239. Abramowski P, et al. 2014. J Neuroimmunol. 274:111. PubMed
  240. Hoeksema M, et al. 2015. J Immunol. 194:3909. PubMed
  241. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  242. Yang Y, et al. 2022. Elife. 11:. PubMed
  243. Clement CC, et al. 2021. Nat Commun. 12:4447. PubMed
  244. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  245. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  246. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  247. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  248. Haka A, et al. 2012. PLoS One. 7:e44823. PubMed
  249. Kaya B, et al. 2020. Cell Reports. 32(5):107979. PubMed
  250. Sztwiertnia I, et al. 2020. PLoS One. 15:e0233789. PubMed
  251. Gierut J, et al. 2015. Stem Cell Res. 15: 165-171. PubMed
  252. Seki T, et al. 2015. J Biochem. 158: 485 - 495. PubMed
  253. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  254. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  255. Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed
  256. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  257. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  258. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  259. Favuzzi E, et al. 2021. Cell. 184(15):4048-4063.e32. PubMed
  260. DiToro D, et al. 2020. Immunity. 650:52. PubMed
  261. Camara A, et al. 2019. Immunity. 50:1467. PubMed
  262. Michaelis KA, et al. 2019. Brain Behav Immun. 82:338. PubMed
  263. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  264. Veremeyko T, et al. 2019. J Neurosci Res. 97:162. PubMed
  265. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  266. Kim MY, et al. 2018. Cell. 173:1439. PubMed
  267. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  268. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  269. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  270. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  271. Yu W, et al. 2022. Nat Commun. 13:3544. PubMed
  272. Ou YC, et al. 2020. ACS Nano. 1.035416667. PubMed
  273. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  274. Zelco A, et al. 2020. Front Cell Neurosci. 0.75625. PubMed
  275. Wang LT, et al. 2020. Cell Rep. 32:108188. PubMed
  276. Hadas R, et al. 2020. JCI Insight. 5:00. PubMed
  277. Draper D, et al. 2012. J Immunol. 188:5327. PubMed
  278. Hohsfield LA, et al. 2020. J Neuroinflammation. 0.902083333. PubMed
  279. Godwin MS, et al. 2019. JCI Insight. 4:e126070. PubMed
  280. Stock M, et al. 2015. Osteoarthritis Cartilage. 23: 1221-1225. PubMed
  281. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  282. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  283. Selvaraj UM et al. 2018. Endocrinology. 159(11):3848-3859 . PubMed
  284. Pinho–Ribeiro FA, et al. 2018. Cell. 173:1083. PubMed
  285. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  286. Hsu M, et al. 2022. Nat Immunol. 23:581. PubMed
  287. Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed
  288. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  289. Wang X, et al. 2022. Front Immunol. 13:864984. PubMed
  290. Galani IE, et al. 2022. STAR Protoc. 3:101151. PubMed
  291. Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed
  292. Da Mesquita S, et al. 2021. Science Advances. 7(21):. PubMed
  293. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  294. Ben-Moshe S, et al. 2019. Nat Metab. 1:899. PubMed
  295. Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed
  296. Wakabayashi T et al. 2018. Cell stem cell. 22(3):384-397 . PubMed
  297. Kaiser T, et al. 2019. Eneuro. 6. PubMed
  298. El Agha E, et al. 2017. Cell Stem Cell. 1.014583333. PubMed
  299. Bhatt D, et al. 2021. J Exp Med. 218:. PubMed
  300. Lu Z, et al. 2021. J Clin Invest. 131:. PubMed
  301. Luo M, et al. 2021. J Immunol. 207:1683. PubMed
  302. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  303. Starikova E, et al. 2021. Front Pharmacol. 12:667572. PubMed
  304. Yu L, et al. 2020. Nat Commun. 2.045833333. PubMed
  305. Liu X, et al. 2019. Mol Cancer Ther. 18:706. PubMed
  306. Klein S, et al. 2016. J Cell Sci. 129: 2573 - 2585. PubMed
  307. Li N, et al. 2022. Nat Commun. 13:7281. PubMed
  308. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  309. Jiang P, et al. 2018. Nat Med. 24:1550. PubMed
  310. Wang X, et al. 2018. Nat Commun. 9:551. PubMed
  311. Pedicone C, et al. 2022. iScience. 25:104170. PubMed
  312. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  313. Reda M, et al. 2022. Nat Commun. 13:4261. PubMed
  314. Li Y, et al. 2022. STAR Protoc. 3:101364. PubMed
  315. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  316. Milich LM, et al. 2021. J Exp Med. 218:. PubMed
  317. Kline JM, et al. 2021. J Biol Chem. :100373. PubMed
  318. Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed
  319. Lu C, et al. 2020. Cancer Cell. 39(1):96-108.e6. PubMed
  320. Yang C, et al. 2020. Cell Host Microbe. 467:27. PubMed
  321. Morein D, et al. 2021. Cells. 10: . PubMed
  322. Zhao Y, et al. 2020. Front Immunol. 2.572222222. PubMed
  323. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  324. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  325. Gago-Lopez N, et al. 2019. EMBO Mol Med. 11:e10697. PubMed
  326. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  327. Uluçkan ö, et al. 2020. Cell Reports. 29(4):844-859.e3.. PubMed
  328. Yoldi G, et al. 2016. Cancer Res . 76: 5857 - 5869. PubMed
  329. Ling Y, et al. 2016. Pharmacol Res. S1043-6618(16)31329-9. PubMed
  330. Armaka M, et al. 2018. Nat Commun. 9:618. PubMed
  331. Lang JF et al. 2019. Nat Commun. 10(1):3415 . PubMed
  332. Theurich S et al. 2017. Cell metabolism. 26(1):171-184 . PubMed
  333. Martin A, et al. 2018. Oncotarget. 9:28364. PubMed
  334. Yan C, et al. 2022. NPJ Precis Oncol. 6:6. PubMed
  335. Phansalkar R, et al. 2021. Elife. 10:. PubMed
  336. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  337. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  338. Wang X, et al. 2021. Theranostics. 11:209. PubMed
  339. Liu SS, et al. 2021. Immunity. :. PubMed
  340. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  341. Willemze RA, et al. 2019. Mol Med. 25:01:00. PubMed
  342. Fransén Pettersson N, et al. 2018. PLoS One. 13:e0203228. PubMed
  343. E O’Koren, R Mathew, D Saban 2016. Sci Rep. 6:20636. PubMed
  344. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  345. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  346. Seeling M, et al. 2013. Proc Natl Acad Sci U S A. 110:10729. PubMed
  347. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  348. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  349. Peng V, et al. 2022. Nat Immunol. 23:619. PubMed
  350. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  351. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  352. Zhang X, et al. 2022. J Exp Clin Cancer Res. 41:246. PubMed
  353. Guan D, et al. 2021. Cell Death Dis. 12:431. PubMed
  354. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  355. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  356. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  357. Dinh HQ, et al. 2020. Immunity. 53(2):319-334.e6. PubMed
  358. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  359. Cong L, et al. 2021. Breast Cancer Res. 23:51. PubMed
  360. De Micheli AJ, et al. 2020. Am J Physiol Cell Physiol. 319:C885. PubMed
  361. Sibler E, et al. 2021. Cells. 10:. PubMed
  362. Oladiran O, et al. 2021. Front Immunol. 12:720733. PubMed
  363. Forte E, et al. 2020. Cell Rep. 30:3149. PubMed
  364. Wang J, et al. 2020. J Hematol Oncol. 0.610416667. PubMed
  365. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  366. Lux A, et al. 2014. Cell Rep. 10:236. PubMed
  367. Madsen P, et al. 2016. J Neurosci. 36: 5128 - 5143. PubMed
  368. Fox B, et al. 2016. PLoS One. 12: 1006189. PubMed
  369. Parker K, Horn L, Ostrand-Rosenberg S 2016. J Leukoc Biol. 100: 463 - 470.. PubMed
  370. Petriello MC, et al. 2018. Toxicol Sci. 162:548. PubMed
  371. Severe N et al. 2019. Cell Stem Cell. 25(4):570-583 . PubMed
  372. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  373. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  374. Sebastian A, et al. 2021. Cells. 10:. PubMed
  375. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  376. Zhu Q, et al. 2021. J Am Heart Assoc. 10:e023491. PubMed
  377. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  378. Parent AV, et al. 2021. Cell Reports. 36(7):109538. PubMed
  379. Ito Y, et al. 2021. Cell Reports. 35(4):109052. PubMed
  380. Ma Y, et al. 2021. Developmental Cell. 56(4):478-493.e11. PubMed
  381. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
  382. Campisi L, et al. 2016. Nat Immunol. 10.1038/ni.3512. PubMed
  383. Holzapfel B, et al. 2015. Biomaterials. 61: 103-114. PubMed
  384. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  385. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  386. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  387. Swanson WB, et al. 2021. Biomaterials. 272:120769. PubMed
  388. Hohsfield LA, et al. 2021. Elife. 10:. PubMed
  389. Sun D, et al. 2020. PLoS Pathog. 16:e1008361. PubMed
RRID
AB_312980 (BioLegend Cat. No. 103115)
AB_312981 (BioLegend Cat. No. 103116)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Spark YG™ 581 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS V475™ anti-mouse CD45 Antibody 30-F11 FC
PE/Fire™ 744 anti-mouse CD45 30-F11 FC
StarBright UltraViolet 740 anti-mouse CD45 30-F11 FC
Go To Top Version: 3    Revision Date: 01/30/2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account